Longevity Klotho Neuro moves to acquire Turn Bio assetsBy adminOctober 2, 20250 Longevity biotech seeks to broaden its therapeutic capabilities with cellular reprogramming and delivery technologies. Longevity-focused biotech Klotho Neurosciences revealed it…
DNA & Genetics Genmab to Acquire Merus for $8B, Expanding Bispecific Antibody Cancer PipelineBy adminSeptember 30, 20250 Genmab has agreed to acquire Merus for approximately $8 billion, the companies said today, in a deal intended to bolster…
DNA & Genetics Pfizer to Acquire Metsera for up to $7.3B, Returning to Obesity Drug RaceBy adminSeptember 23, 20250 Pfizer has agreed to acquire Metsera for up to $7.3 billion, the companies said, in a deal that returns the…
